Dr. Polley clarifies when to use stimulants in patients with ADHD and substance use disorders and how to address the underlying addiction.

From liraglutide (Saxenda) to tirzepatide (Mounjaro), new weight loss medications are reshaping the treatment of diabetes and obesity. But what’s their impact in psychiatry?

How to help patients build fulfilling lives even in the face of unremitted illness.

How post is postpartum? And how fast do you need to intervene?

We look at the ideal times to intervene for antipsychotic weight gain and panic attacks.

We have three newly approved meds for dementia. Brexpiprazole (Rexulti) for agitation, and donanemab (Kisunla) and lecanemab (Leqembi) for the core features of Alzheimer’s. Dr. Collier explains why none of these are first-line.

We have 30 stimulant formulations, but do all deserve prizes? We find a few with niche advantages, and three that rise to the top.

Sometimes we have a window of opportunity to make a difference. In this series we discuss time-frames where panic, clozapine, and metformin have the greatest benefits.